What does Fulcrum Therapeutics, Inc. do?

Jun 22 2025 06:55 PM IST
share
Share Via
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on treating genetically defined rare diseases. As of March 2025, it has a market cap of $347.09 million and reported a net profit of -$18 million.
Overview:
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases within the Pharmaceuticals & Biotechnology industry.

Financial Snapshot:
Most recent Net Profit: -18 Million (Quarterly Results - Mar 2025)
Market cap: USD 347.09 Million (Micro Cap)

Key Metrics:
P/E: 252.00
Dividend Yield: 0.00%
Debt Equity: -0.98
Return on Equity: 0.68%
Price to Book: 1.52

Contact Details:
Address: 26 Landsdowne St, CAMBRIDGE MA: 02139-4216
Tel: ['1 617 6518851', '1 212 3621200']
Fax: 1 302 6555049
Website: http://www.fulcrumtx.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Fulcrum Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:34 PM IST
share
Share Via
Is Fulcrum Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:11 AM IST
share
Share Via
How big is Fulcrum Therapeutics, Inc.?
Jun 22 2025 06:09 PM IST
share
Share Via